Acceleron Pharma Inc. buy marge
Start price
21.06.15
/
50%
€27.02
Target price
21.12.15
€32.00
Performance (%)
49.03%
End price
21.12.15
€40.27
Summary
This prediction ended on 21.12.15 with a price of €40.27. With a performance of 49.03% the BUY prediction by marge was a big success. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Acceleron Pharma Inc. | - | - | - | - |
iShares Core DAX® | 2.722% | -4.863% | 12.025% | 9.678% |
iShares Nasdaq 100 | 4.546% | -7.240% | 26.309% | 36.290% |
iShares Nikkei 225® | 6.353% | -6.674% | 10.125% | 4.745% |
iShares S&P 500 | 3.194% | -3.832% | 22.640% | 35.492% |
Comments by marge for this prediction
In the thread Acceleron Pharma Inc. diskutieren
Acceleron Pharma
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)